ArticleRheumatology and therapy2026

Subcutaneous Belimumab Demonstrates Consistent Steady-State Pharmacokinetics and is Well Tolerated in Paediatric Patients with SLE in China: An Open-Label Study.

Caifeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.